Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Cosnova, officially known as Cosnova GmbH, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Germany. Established in 2004, the company has grown steadily to serve major markets across Europe and beyond, specialising in the development and production of high-quality pharmaceutical formulations.
With a focus on innovation and compliance, Cosnova’s core products include a wide range of prescription and over-the-counter medicines, distinguished by their rigorous quality standards and tailored formulations. The company’s expertise in pharmaceutical preparation manufacturing has earned it a notable reputation within the industry, positioning it as a trusted partner for healthcare providers and pharmaceutical companies alike.
-17 vs industry average
Cosnova’s score of 25 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Cosnova yet.
Cosnova, a company within the Pharmaceutical Preparation Manufacturing industry headquartered in Germany, has established climate commitments. While specific, recent absolute carbon emissions data for Cosnova is not publicly available, the company has outlined reduction targets.
Cosnova committed to reducing its absolute CO2 emissions by 12% within the first three years, starting from 2018 and aiming for this by 2021. This target applies to both Scope 1 and Scope 2 emissions.
As Cosnova's data is cascaded, its emissions reporting and climate commitments are inherited from its parent organisation, cosnova GmbH. Further details on specific emissions figures and achievements would be available through this corporate family relationship.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more